Kulmus Genetics
High-throughput DNA Synthesis for Synthetic-biology Applications
Company Overview
Snapshot
Founded in January 2025 by Rami Verbin and Shay Shilo, Kulmus Genetics operates with 1–10 employees. The company has raised $50,000 across one funding round. In February 2025, Kulmus Genetics secured its initial funding, marking an early milestone in its development.
Business overview
Kulmus Genetics is developing a high-throughput DNA-synthesis solution designed for biotechnology and synthetic-biology organizations. Its platform aims to enhance the scale and throughput of synthetic DNA production, which is critical for workflows in biological research, engineered organisms, diagnostics, therapeutics, and agricultural biotechnology. The company serves the Health Tech & Life Sciences sector, focusing on B2B business models.
Log in to access full profile ›Company Intelligence Q&A
- When was Kulmus Genetics founded?
- Kulmus Genetics was founded in January 2025.
- Who are the founders of Kulmus Genetics?
- The co-founders of Kulmus Genetics are Rami Verbin and Shay Shilo.
- What is the primary focus of Kulmus Genetics?
- Kulmus Genetics is developing a high-throughput DNA-synthesis solution for biotechnology and synthetic-biology applications.
- What is the total funding raised by Kulmus Genetics?
- Kulmus Genetics has raised a total of $50,000 across one funding round.
- When did Kulmus Genetics secure its last funding round?
- Kulmus Genetics secured its last funding round in February 2025, raising $50,000.